Researchers from Circle Pharma Inc. have presented preclinical data for CID-078, a novel orally bioavailable cyclin A/B Rxl macrocycle being developed for the treatment of patients with lung cancer.

When you get right down to it, there is really nothing wrong with a late-model Firebird or Camaro that an infusion of horsepower won't cure. GM engineers hit a home run with the styling and handling ...